HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gema C González-Muñoz Selected Research

2- chloro- 5,6- dihydro- 5,6- diacetyldibenzo(b,f)(1,4,5)thiadiazepine

9/2014ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gema C González-Muñoz Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
09/2014 - 11/2009
3Neurodegenerative Diseases (Neurodegenerative Disease)
09/2014 - 12/2010
3Neuroblastoma
09/2014 - 12/2010
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2012

Drug/Important Bio-Agent (IBA)

2Cholinergic Agents (Cholinergics)IBA
07/2010 - 11/2009
1Pharmaceutical PreparationsIBA
09/2014
12- chloro- 5,6- dihydro- 5,6- diacetyldibenzo(b,f)(1,4,5)thiadiazepineIBA
09/2014
1dibenzo(1,4,5)thiadiazepineIBA
06/2014
1Tacrine (Cognex)FDA Link
01/2012
1CalciumIBA
06/2011
1Okadaic AcidIBA
06/2011
1Neuroprotective AgentsIBA
06/2011
1Peptides (Polypeptides)IBA
06/2011
1phenothiazineIBA
12/2010
1Free RadicalsIBA
12/2010
1tacrine-8-hydroxyquinolineIBA
07/2010
1AntioxidantsIBA
07/2010
1CopperIBA
07/2010
1GlutamatesIBA
11/2009

Therapy/Procedure

1Therapeutics
12/2010